The term LOC643770 Inhibitors characterizes a specialized class of chemical compounds strategically designed to modulate the activity of LOC643770, a molecular target currently the subject of scientific investigation. These inhibitors are meticulously crafted through principles rooted in medicinal chemistry, with a primary focus on selectively interfering with the normal functions of LOC643770 within cellular processes. The structural features of LOC643770 Inhibitors undergo a rigorous optimization process, often involving computational modeling and structure-activity relationship studies, to refine their molecular configurations for precise binding to the target.
The significance of LOC643770 Inhibitors lies in their potential to disrupt the biochemical activities associated with LOC643770, a molecular entity believed to play a role in various biological pathways. Researchers in this field delve into the three-dimensional structure of LOC643770 and its binding interactions with inhibitors, aiming to unravel the intricate molecular mechanisms underlying inhibition. The study of LOC643770 Inhibitors contributes to a broader understanding of cellular processes, offering insights into the roles played by LOC643770 in diverse biological pathways and expanding our knowledge of the regulatory networks governing cellular activities. This research not only advances our comprehension of the molecular intricacies surrounding LOC643770 but also contributes to the broader scientific understanding of molecular targets and their involvement in fundamental cellular functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine incorporates into RNA and DNA, disrupting nucleic acid function and potentially inhibiting RNA expression. | ||||||
β-Lapachone | 4707-32-8 | sc-200875 sc-200875A | 5 mg 25 mg | $110.00 $450.00 | 8 | |
β-Lapachone generates reactive oxygen species that can lead to DNA damage and potentially affect RNA expression. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
5-Fluorouracil is metabolized to nucleotide analogs that can inhibit RNA processing and function. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D intercalates into DNA, inhibiting RNA polymerase and thus transcription, including that of lncRNAs. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
DRB inhibits RNA polymerase II, potentially decreasing RNA transcription, including lncRNAs like LINC02453. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
α-Amanitin inhibits RNA polymerase II, which is responsible for transcribing mRNA and some lncRNAs. | ||||||
Ribavirin | 36791-04-5 | sc-203238 sc-203238A sc-203238B | 10 mg 100 mg 5 g | $62.00 $108.00 $210.00 | 1 | |
Ribavirin can mutate RNA and inhibit RNA dependent RNA polymerase, which could affect RNA stability. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $99.00 | 5 | |
Cordycepin acts as a chain terminator during RNA transcription, potentially affecting lncRNA levels. | ||||||
Quinacrine, Dihydrochloride | 69-05-6 | sc-204222 sc-204222B sc-204222A sc-204222C sc-204222D | 100 mg 1 g 5 g 200 g 300 g | $45.00 $56.00 $85.00 $3193.00 $4726.00 | 4 | |
Quinacrine intercalates into DNA and RNA, which could disrupt transcription processes and affect lncRNA expression. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Camptothecin inhibits DNA topoisomerase I, which is involved in DNA transcription processes affecting RNA synthesis. | ||||||